Key result
Unrecognized diabetes in STEMI is not linked to greater myocardial damage compared to non-diabetics.
Why the study?
The mechanisms underlying worse clinical outcomes in previously unrecognized diabetic patients in STEMI are unclear, leading to the hypothesis that poor chronic glucose control might relate to greater myocardial damage.
Does previously unrecognized diabetes with HbA1c > 6.5 increase myocardial damage in patients presenting with STEMI?
Observational (n=105)
No
Does previously unrecognized diabetes with HbA1c > 6.5 increase myocardial damage in patients presenting with STEMI?
Previously unrecognized diabetes with HbA1c > 6.5 is not associated with greater myocardial damage in patients presenting with STEMI.
Answers are grounded in this paper and cite their sources.
No greater troponin release seen with unrecognized diabetes in STEMI; leaves open whether HbA1c screening affects prognosis.
Objective: The mechanisms underlying worse clinical outcomes in previously unrecognized diabetic (DM) patients in ST-elevation myocardial infarction (STEMI) are unclear. It was hypothesized that poor chronic glucose control might be related to greater myocardial damage. Material and Method: 51 newly diagnosed DM patients with glycated hemoglobin A1c (HbA1c) > 6.5 comprised the DM group, 54 sex- and age-matched individuals with normal glucose metabolism served as the non-DM group. Each patient underwent primary angioplasty for STEMI. The levels of cardiac specific markers before angioplasty, during angioplasty, at 6, 12, and 18 h after angioplasty were recorded. SPSS 10 package program was used to analyse data. Results: In both DM and non-DM groups troponin peaked at 6 h. Peak troponin levels were similar in both groups (diabetics, 22.89 ± 18.19 vs. non-diabetics, 32.67 ± 17.68 ng/ml, p=0.168). Conclusions: HbA1c > 6.5 is not related to extent of infarction in previously unrecognized DM patients presenting with STEMI. Future studies assessing the effects of other factors unrelated to chronic glucose control on myocardial damage and cardiovascular event rates in these patients would be of great interest.
No takes yet. Share an insight, caveat, or question.
Aslan et al. (2021) conducted an observational in ST-elevation myocardial infarction (STEMI) with previously unrecognized diabetes (n=105). Newly diagnosed diabetes (HbA1c > 6.5) vs. Normal glucose metabolism was evaluated on Peak troponin levels at 6 hours (ng/ml) (p=0.168). An HbA1c > 6.5 in previously unrecognized diabetes patients presenting with STEMI was not associated with greater myocardial damage compared to non-diabetics.
Synapse has enriched 10 related papers. Consider them for comparative context: